CoChat
Sign Up
Cited by 3Treatment of Major DepressionPsychological Treatments and DisordersNeurotransmitter Receptor Influence on Behavior

Bupropion and Depressions

Rujescu, Dan, Röttig, Stephan, Krause, Tim Johannes·2020·NeuroPsychopharmacotherapy
DOI 10.1007/978-3-319-56015-1_83-1
Open this paper in CoChat — free account

Integrity signals

Registry

Crossref · 10.1007/978-3-319-56015-1_83-1

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Methamphetamine's half-life of 10 to 12 hours is significantly longer than cocaine's 1-hour half-life, leading to more prolonged effects.

    “In addition, methamphetamine's half-life of 10 to 12 hours is significantly longer than cocaine's 1-hour half-life, leading to more prolonged effects.105”

    From The ASAM/AAAP Clinical Practice Guideline on the Management of Stimulant Use Disorder (2024) · cites this paper as [105]

  • Cocaine and ATS both increase brain dopamine signaling; cocaine blocks dopamine reuptake, while methamphetamine increases dopamine release and blocks reuptake, producing much higher concentrations.

    “Cocaine and ATS both increase dopamine signaling in the brain 105 ; cocaine blocks the reuptake of dopamine, whereas methamphetamine both increases dopamine release and blocks its reuptake, resulting in much higher concentrations.105”

    From The ASAM/AAAP Clinical Practice Guideline on the Management of Stimulant Use Disorder (2024) · cites this paper as [105]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Related

Authors
Rujescu, D., Röttig, S., & Krause, T. J.
Affiliations
Martin Luther University Halle-Wittenberg (DE)
Corresponding author
Rujescu, Dan
ORCID
Rujescu, Dan
Venue
NeuroPsychopharmacotherapy
Publisher
Springer International Publishing
Published
2020
Pages
1-10
DOI
10.1007/978-3-319-56015-1_83-1
OpenAlex
W3032251258
Cited by
2
References
17
Citations by year
2024: 1 · 2022: 1
FWCI
0.59
Type
book chapter
Language
en
Open access
closed
Licence
Locations
Springer eBooks (publishedVersion)
Topics
  • Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
  • Social Sciences › Psychology › Clinical Psychology › Psychological Treatments and Disorders
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Keywords
bupropion, major depressive disorder, seasonal affective disorder, nicotine dependence, antidepressants, adverse effects, weight gain, sexual dysfunction, QT prolongation, seizures, drug augmentation, serotonergic antidepressants

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review